Keywords: GlaxoSmithKline, 2009 financial results, R&D refocus, Emerging markets,

GlaxoSmithKline to refocus some research and seek efficiencies, despite posting huge 4th-qtr 2009 profits rise; applause from Science Minister

Article | 05 February 2010

Print This

Although not confirming recent speculation of 3,000 or so job cuts, UK headquartered drugs giant GlaxoSmithKline revealed that it plans to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in